🔎 Trials Near Me

Beranda › Kanker Ovarium › Wisconsin › Madison

Uji klinis Kanker Ovarium di Madison, WI

13 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Madison (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Menerima pesertaFase 2/3
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Menerima pesertaFase 2
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Semua usia · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • University of Wisconsin Carbone Cancer Center, Madison
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Menerima pesertaFase 2
  • Research Site, Madison
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Menerima pesertaFase 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Menerima pesertaFase 1
  • University of Wisconsin - Carbone Cancer Center, Madison
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213791

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Menerima pesertaFase 2
  • University of Wisconsin, Madison
Usia 18 ke atas · Wanita · Diperbarui 14 Sep 2026 · NCT06787612

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

Menerima pesertaStudi observasional
  • UW Carbone Cancer Center, Madison
Usia 18 ke atas · Wanita · Diperbarui 27 Agu 2026 · NCT07125209

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Menerima peserta
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Usia 35 hingga 50 · Wanita · Diperbarui 7 Agu 2026 · NCT04251052

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Menerima pesertaFase 2
  • University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
Usia 18 hingga 100 · Wanita · Diperbarui 13 Jul 2026 · NCT05887609

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Menerima pesertaFase 1/2
  • University of Wisconsin, Madison
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Menerima pesertaFase 1
  • University of Wisconsin Carbone Cancer Center, Madison
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT05568680

Uji klinis Kanker Ovarium di kota lain

Studi lain di Madison

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.